NCT02400242 2024-07-09
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
Celgene
Phase 1 Terminated
Clinical Trials
6 trialsNCT01583283 2022-02-23
Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma
Celgene
Phase 1 Completed
NCT00792506 2022-02-02
Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
Italfarmaco
Phase 2 Terminated
NCT00667082 2017-11-22
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
Celgene
Phase 1 Completed
NCT01580371 2016-10-06
CKD-581
Chong Kun Dang Pharmaceutical
Phase 1 Completed
NCT00005624 2012-09-25
CI-994 in Treating Patients With Advanced Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed